Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Survival curves help decrease anxiety for women with BRCA1/2 mutations
February 23rd, 2006
Individualized cancer survival curves help decrease anxiety and enhance decision-making for women with BRCA1/2 mutations. "Women with BRCA 1/2 mutations are faced with complex decisions about breast and ovarian cancer risk management. This study was conducted to determine the effect of a tailored decision support system (DSS) that provides individualized survival and cancer incidence curves specific to expected outcomes of alternative management strategies," reported investigators at the University of Pennsylvania. K. Armstrong and colleagues explained, "This was a double-blind, randomized controlled trial of 32 women with BRCA...
Source: Women's Health Weekly (2006-02-23)
|